SMTI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SMTI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-06-10), Sanara MedTech's Beta is 1.23.
The historical data trend for Sanara MedTech's Beta can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sanara MedTech Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Beta | Get a 7-Day Free Trial | 3.02 | 2.61 | 2.03 | 1.50 | 1.14 |
Sanara MedTech Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Beta | Get a 7-Day Free Trial | 1.22 | 1.18 | 1.15 | 1.14 | 1.13 |
For the Medical Instruments & Supplies subindustry, Sanara MedTech's Beta, along with its competitors' market caps and Beta data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Sanara MedTech's Beta distribution charts can be found below:
* The bar in red indicates where Sanara MedTech's Beta falls into.
Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.
Sanara MedTech (NAS:SMTI) Beta Explanation
Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.
Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)
Thank you for viewing the detailed overview of Sanara MedTech's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.
Eric D Major | director | 751 MILLER DRIVE SE, LEESBURG VA 20175 |
Zachary B. Fleming | officer: President - Surgical Div. | 1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102 |
Shawn M. Bowman | officer: President - Wound Care Div. | 1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102 |
Rebecca E Mcmahon | officer: President - R&D | 1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102 |
Sara N Ortwein | director | 5959 LAS COLINAS BOULEVARD, IRVING TX 75039-2298 |
Robert Andrew Desutter | director | 1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102 |
Eric D Tanzberger | director | 1929 ALLEN PARKWAY, HOUSTON TX 77219 |
Christopher A. Morrison | officer: President - Telehealth Svcs. | 1200 SUMMIT AVENUE, SUITE 414, FORT WORTH TX 76102 |
Roszell Iii Mack | director | 1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102 |
Cgi Cellerate Rx, Llc | 10 percent owner | C/O THE CATALYST GROUP, INC., 7500 RIALTO BLVD., BLDG. II, SUITE 220, AUSTIN TX 78735 |
Catalyst Rochal, Llc | 10 percent owner | C/O THE CATALYST GROUP, INC., 7500 RIALTO BLVD., BLDG. II, SUITE 220, AUSTIN TX 78735 |
Bradley J. Gurasich | 10 percent owner | C/O THE CATALYST GROUP, INC., 7500 RIALTO BLVD., BLDG. II, SUITE 220, AUSTIN TX 78735 |
J Michael Carmena | director, officer: Principal Executive Officer | 1200 SUMMIT AVE STE 414, FORT WORTH TX 76102 |
Michael D. Mcneil | officer: Chief Financial Officer | 1200 SUMMIT AVE, STE 414, FORT WORTH TX 76102 |
Catalyst Group, Inc. | 10 percent owner | 1375 ENCLAVE PARKWAY, HOUSTON TX 77077 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 05-26-2022
By GuruFocusNews GuruFocusNews • 04-04-2022
By Marketwired • 09-12-2023
By Value_Insider Value_Insider • 11-14-2022
By sperokesalga sperokesalga • 05-15-2023
By Marketwired • 08-02-2023
By Value_Insider Value_Insider • 11-03-2022
By GuruFocus Research • 11-13-2023
By PurpleRose PurpleRose • 08-15-2022
By Marketwired • 10-30-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.